Sonographic monitoring of mass effect in stroke patients treated with hypothermia. Correlation with intracranial pressure and matrix metalloproteinase 2 and 9 expression

Journal of the Neurological Sciences

Volumn 276, Issue 1-2, 2009, Pages 75-78

  Horstmann, S ^a   Koziol, J A ^c   Martinez Torres, F ^a   Nagel, S ^a,d   Gardner, H ^b   Wagner, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NOVARTIS   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cerebrovascular disease; Matrix metalloproteinases; Neuroradiology; Stroke

Indexed keywords

ANALGESIC AGENT; GELATINASE A; GELATINASE B;

ADOLESCENT; ADULT; AGED; ALLOPATHY; ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; BODY TEMPERATURE; BRAIN DAMAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; INDUCED HYPOTHERMIA; INTRACRANIAL PRESSURE; INTRACRANIAL PRESSURE MONITORING; INTUBATION; MALE; MIDDLE CEREBRAL ARTERY; NON INVASIVE PROCEDURE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SEDATION; STROKE; STROKE PATIENT; ZYMOGRAPHY;

AGED; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INTRACRANIAL PRESSURE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MONITORING, PHYSIOLOGIC; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 58149159848     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.08.038     Document Type: Article

References (26)

1. Hacke W., Schwab S., Horn M., Spranger M., De Georgia M., and von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53 (1996) 309-315
2. Ropper A. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med 314 (1986) 953-958
3. Pullicino P.M., Alexandrov A.V., Shelton J.A., Alexandrova N.A., Smurawska L.T., and Norris J.W. Mass effect and death from severe acute stroke. Neurology 49 (1997) 1090-1095
4. Seidel G., Gerriets T., Kaps M., and Missler U. Dislocation of the third ventricle due to space-occupying stroke evaluated by transcranial duplex sonography. J Neuroimaging 6 (1996) 227-230
5. Stolz E., Gerriets T., Fiss I., Babacan S.S., Seidel G., and Kaps M. Comparison of transcranial color-coded duplex sonography and cranial CT measurements for determining third ventricle midline shift in space-occupying stroke. AJNR Am J Neuroradiol 20 (1999) 1567-1571
6. Gerriets T., Stolz E., Konig S., Babacan S., Fiss I., Jauss M., et al. Sonographic monitoring of midline shift in space-occupying stroke: an early outcome predictor. Stroke 32 (2001) 442-447
7. Gerriets T., Goertler M., Stolz E., Postert T., Sliwka U., Schlachetzki F., et al. Feasibility and validity of transcranial duplex sonography in patients with acute stroke. J Neurol Neurosurg Psychiatry 73 (2002) 17-20
8. Schwab S., Schwarz S., Spranger M., Keller E., Bertram M., and Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29 (1998) 2461-2466
9. Wagner S., Nagel S., Kluge B., Schwab S., Heiland S., Koziol J., et al. Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia. Brain Res 984 (2003) 63-75
10. Montaner J., Alvarez-Sabin J., Molina C., Angles A., Abilleira S., Arenillas J., et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32 (2001) 1759-1766
11. Montaner J., Molina C.A., Monasterio J., Abilleira S., Arenillas J.F., Ribo M., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 (2003) 598-603
12. Horstmann S., Kalb P., Koziol J., Gardner H., and Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34 (2003) 2165-2170
13. Lapchak P.A., Chapman D.F., and Zivin J.A. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 31 (2000) 3034-3040
14. Bertram M., Khoja W., Ringleb P., and Schwab S. Transcranial colour-coded sonography for the bedside evaluation of mass effect after stroke. Eur J Neurol 7 (2000) 639-646
15. Horstmann S., Su Y., Koziol J., Meyding-Lamade U., Nagel S., and Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci 251 (2006) 82-86
16. Llompart Pou J.A., Abadal Centellas J.M., Palmer Sans M., Perez Barcena J., Casares Vivas M., Homar Ramirez J., et al. Monitoring midline shift by transcranial color-coded sonography in traumatic brain injury. A comparison with cranial computerized tomography. Intensive Care Med 30 (2004) 1672-1675
17. Tang S.C., Huang S.J., Jeng J.S., and Yip P.K. Third ventricle midline shift due to spontaneous supratentorial intracerebral hemorrhage evaluated by transcranial color-coded sonography. J Ultrasound Med 25 (2006) 203-209
18. Gerriets T., Seidel G., Fiss I., Modrau B., and Kaps M. Contrast-enhanced transcranial color-coded duplex sonography - efficiency and validity. Neurology 52 (1999) 1133-1137
19. Kelly P.J., Morrow J.D., Ning M., Koroshetz W., Lo E.H., Terry E., et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39 (2008) 100-104
20. Burggraf D., Martens H.K., Dichgans M., and Hamann G.F. Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke. Thromb Haemost 98 (2007) 963-969
21. Heo J.H., Lucero J., Abumiya T., Koziol J.A., Copeland B.R., and del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19 (1999) 624-633
22. Rosenberg G.A., Navratil M., Barone F., and Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16 (1996) 360-366
23. Clark A.W., Krekoski C.A., Bou S.S., Chapman K.R., and Edwards D.R. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238 (1997) 53-56
24. Mandler R.N., Dencoff J.D., Midani F., Ford C.C., Ahmed W., and Rosenberg G.A. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain 124 (2001) 493-498
25. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
26. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030